High Throughput Screening (HTS) Market Will Reach $30.91 Billion By 2025: Grand View Research, Inc.
The
global high throughput screening market size is expected
to generate a revenue of USD 30.91 billion by 2025, according to a new report
by Grand View Research, Inc., exhibiting a CAGR of 7.89% during the forecast
period. Increasing adoption of faster and accurate technology by pharmaceutical
companies to introduce newer molecules in the market is anticipated to provide
a significant push to the market.
High
throughput screening is used for testing of molecules in development phase on
various grounds such as chemical, pharmaceutical, and genetic reactions. These
screenings help in drug design and development based on real time results and
near natural conditions that mimic natural reactions between the molecule and
the body.
Moreover,
this method can be fully automated using required hardware and software capable
of handling a fully automated process along with data storage units that store
and process considerable amount of data in short span of time.
As
of 2016, approximately 55.0% of high throughput screening tests are carried out
based on the cell based assays. Cell based assays are used majorly owing to the
results that can be obtained at cellular levels along with pathways and
mechanism.
These
assays range from cytotoxic tests, including apoptosis, to cell metabolic
assays. One more major technology implantation is the introduction of 3D – cell
culture, which can help mimic natural conditions that give more accurate
results and reactions to tests carried on. This trend is estimated to support
the growth of the market during the forecast period.
Browse full
research report on High Throughput Screening (HTS) Market:
www.grandviewresearch.com/industry-analysis/high-throughput-screening-market
Further key
findings from the study suggest:
- The market is driven by increasing competition
between pharmaceutical companies to introduce novel molecules
- Emerging 3D cell culture technology that
provides better results in real time is set to boost the market
- North America emerged as the clear hotspot for
the development and adoption of this technology and had a major share in
the market
- Emerging regions such as Asia Pacific and Latin
America are set to witness considerable growth in demand over the forecast
period driven by the need of newer molecules to cure various diseases
- Some of the key players in this market are
Agilent Technologies, Inc., Danaher Corporation, Thermofisher Scientific,
Inc., PerkinElmer, Inc. and Tecan Group Ltd., Merck Millipore, Bio-Rad
laboratories, Hamilton Company, Axxam S.p.A., and Aurora Biomed.
Browse more
reports of this category by Grand View Research: www.grandviewresearch.com/industry/biotechnology
Grand View Research has segmented the global high throughput screening
market by technology, application, and region:
High
Throughput Screening Technology Outlook (Revenue, USD Billion, 2014 -
2025)
- Cell-based
Assays
- Fluorometric
Imaging Plate Reader Assays
- Clinical
applications (Cardiotoxicity assays)
- In-vitro
studies (Pharmacophores identification in drug discovery)
- Reporter
based Assays
- Clinical
applications (Reporter assay in biological systems analysis)
- In-vitro
studies (Genetic reporter assays in cloning tools for live-cell work)
- 3D -
Cell Cultures
- Clinical
applications (Regenerative medicine)
- In-vitro
studies (Drug discovery, Molecular cell biology)
- Ultra
High Throughput Screening
High
Throughput Screening Application Outlook (Revenue, USD Billion,
2014 - 2025)
- Drug
discovery programs
- Chemical
biology programs
- Biochemical
screening
- Cell-
& organ-based screening
High
Throughput Screening Regional Outlook (Revenue, USD
Billion, 2014 - 2025)
- North
America
- U.S.
- Canada
- Europe
- Germany
- U.K
- Asia
Pacific
- China
- Japan
- Latin
America
- Brazil
- MEA
- South
Africa
Access
Press Release By Grand View Research: www.grandviewresearch.com/press-release/global-high-throughput-screening-market
About Grand
View Research:
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco.
The company provides syndicated research reports, customized research
reports, and consulting services. To help clients make informed business
decisions, we offer market intelligence studies ensuring relevant and fact-based
research across a range of industries, from technology to chemicals, materials
and healthcare.
Comments
Post a Comment